{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:06:53Z","timestamp":1789139213264,"version":"build-2803163510"},"reference-count":116,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"National Natural Science Foundation of China","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"National Natural Science Foundation of China","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"National Natural Science Foundation of China","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"National Natural Science Foundation of China","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"National Natural Science Foundation of China","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"National Natural Science Foundation of China","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"National Natural Science Foundation of China","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"National Natural Science Foundation of China","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"National Natural Science Foundation of China","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"National Natural Science Foundation of China","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"National Natural Science Foundation of China","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"National Natural Science Foundation of China","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"National Natural Science Foundation of China","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"Macao Youth Scholars Program","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"Macao Youth Scholars Program","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"Macao Youth Scholars Program","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"Macao Youth Scholars Program","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"Macao Youth Scholars Program","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"Macao Youth Scholars Program","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"Macao Youth Scholars Program","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"Macao Youth Scholars Program","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"Macao Youth Scholars Program","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"Macao Youth Scholars Program","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"Macao Youth Scholars Program","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"Macao Youth Scholars Program","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"Macao Youth Scholars Program","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"Macao Youth Scholars Program","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"Science and Technology Foundation of Guangzhou City","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"Scientific research projects of Guangdong Bureau of Traditional Chinese Medicine","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"Innovative Team Project of Guangdong Province General University","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"Fund of Science and Technology Innovation Strategy of Guangdong Province","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"2022 Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immune Diseases","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["82104495"],"award-info":[{"award-number":["82104495"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["82174161"],"award-info":[{"award-number":["82174161"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["AM2021023"],"award-info":[{"award-number":["AM2021023"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["2022A1515010395"],"award-info":[{"award-number":["2022A1515010395"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["2021A1515012573"],"award-info":[{"award-number":["2021A1515012573"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["202102010257"],"award-info":[{"award-number":["202102010257"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["SZ2021ZZ21"],"award-info":[{"award-number":["SZ2021ZZ21"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["20212088"],"award-info":[{"award-number":["20212088"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["20202075"],"award-info":[{"award-number":["20202075"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["2022KCXTD007"],"award-info":[{"award-number":["2022KCXTD007"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["YN2020MS13"],"award-info":[{"award-number":["YN2020MS13"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["191900105"],"award-info":[{"award-number":["191900105"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["MY2022KF05"],"award-info":[{"award-number":["MY2022KF05"]}]},{"name":"2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Proprotein convertase subtilisin\/kexin type 9 (PCSK9) is a secretory serine protease synthesized primarily by the liver. It mainly promotes the degradation of low-density lipoprotein receptor (LDL-R) by binding LDL-R, reducing low-density lipoprotein cholesterol (LDL-C) clearance. In addition to regulating LDL-R, PCSK9 inhibitors can also bind Toll-like receptors (TLRs), scavenger receptor B (SR-B\/CD36), low-density lipoprotein receptor-related protein 1 (LRP1), apolipoprotein E receptor-2 (ApoER2) and very-low-density lipoprotein receptor (VLDL-R) reducing the lipoprotein concentration and slowing thrombosis. In addition to cardiovascular diseases, PCSK9 is also used in pancreatic cancer, sepsis, and Parkinson\u2019s disease. Currently marketed PCSK9 inhibitors include alirocumab, evolocumab, and inclisiran, as well as small molecules, nucleic acid drugs, and vaccines under development. This review systematically summarized the application, preclinical studies, safety, mechanism of action, and latest research progress of PCSK9 inhibitors, aiming to provide ideas for the drug research and development and the clinical application of PCSK9 in cardiovascular diseases and expand its application in other diseases.<\/jats:p>","DOI":"10.3390\/cells11192972","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T21:14:28Z","timestamp":1664140468000},"page":"2972","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["PCSK9 Inhibition: From Current Advances to Evolving Future"],"prefix":"10.3390","volume":"11","author":[{"given":"Chunping","family":"Liu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"},{"name":"Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou 510080, China"},{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-4355","authenticated-orcid":false,"given":"Dongyue","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Health Science Center, Shenzhen University, Shenzhen 518060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Hong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhong","family":"Liao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhe","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Neuroscience, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Cen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Neuroscience, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-6298","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5551\/jat.55400","article-title":"An Update on the Role of PCSK9 in Atherosclerosis","volume":"27","author":"Yurtseven","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: A key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/embor.2011.205","article-title":"Mechanistic implications for LDL receptor degradation from the PCSK9\/LDLR structure at neutral pH","volume":"12","author":"Bottomley","year":"2011","journal-title":"EMBO Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.111.057406","article-title":"Gene inactivation of proprotein convertase subtilisin\/kexin type 9 reduces atherosclerosis in mice","volume":"125","author":"Denis","year":"2012","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.115.018531","article-title":"Circulating Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors","volume":"133","author":"Leander","year":"2016","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2016.03.010","article-title":"PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study","volume":"248","author":"Cheng","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1105803","article-title":"Effect of a monoclonal antibody to PCSK9 on LDL cholesterol","volume":"366","author":"Stein","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2017.04.023","article-title":"New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4\/NF-\u03baB pathway","volume":"262","author":"Tang","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/path.4630","article-title":"Local effects of human PCSK9 on the atherosclerotic lesion","volume":"238","author":"Giunzioni","year":"2016","journal-title":"J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cvr\/cvw053","article-title":"Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms","volume":"110","author":"Tavori","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2011.11.026","article-title":"Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels","volume":"220","author":"Ferri","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1074\/jbc.M110.199042","article-title":"A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor","volume":"286","author":"Yamamoto","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/ars.2014.6054","article-title":"Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta","volume":"22","author":"Ding","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cvr\/cvv178","article-title":"Cross-talk between LOX-1 and PCSK9 in vascular tissues","volume":"107","author":"Ding","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbrc.2017.02.085","article-title":"PCSK9 regulates the chemokine receptor CCR2 on monocytes","volume":"485","author":"Grune","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/cvr\/cvz262","article-title":"Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines","volume":"116","author":"Liu","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cammisotto, V., Pastori, D., Nocella, C., Bartimoccia, S., Castellani, V., Marchese, C., Scavalli, A.S., Ettorre, E., Viceconte, N., and Violi, F. (2020). PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation. Antioxidants, 9.","DOI":"10.3390\/antiox9040296"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"258ra143","DOI":"10.1126\/scitranslmed.3008782","article-title":"PCSK9 is a critical regulator of the innate immune response and septic shock outcome","volume":"6","author":"Walley","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13287-019-1342-6","article-title":"Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR\/Cas-mediated genetic correction, and productive hepatitis C virus infection","volume":"10","author":"Caron","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1172\/JCI137536","article-title":"Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes","volume":"130","author":"Gan","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cawley, N.X., Lyons, A.T., Abebe, D., Wassif, C.A., and Porter, F.D. (2020). Evaluation of the Potential Role of Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9) in Niemann-Pick Disease, Type C1. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072430"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ymthe.2018.10.016","article-title":"Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics","volume":"27","author":"Khoshnejad","year":"2019","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40256-018-0270-7","article-title":"Comparative Effectiveness of Inclisiran 100, 300, and 500 mg in a Population with Hyperlipidemia: A Network Meta-Analysis of Randomized Controlled Trials","volume":"18","author":"Wang","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jacc.2018.04.054","article-title":"The Evolving Future of PCSK9 Inhibitors","volume":"72","author":"Rosenson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ahj.2014.07.028","article-title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY outcomes trial","volume":"168","author":"Schwartz","year":"2014","journal-title":"Am. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1701131","article-title":"Cognitive Function in a Randomized Trial of Evolocumab","volume":"377","author":"Giugliano","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"48865","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"Benjannet","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2174\/092986710791299948","article-title":"Regulatory effects of peptides from the pro and catalytic domains of proprotein convertase subtilisin\/kexin 9 (PCSK9) on low-density lipoprotein receptor (LDL-R)","volume":"17","author":"Basak","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.taap.2019.03.018","article-title":"Emerging role of proprotein convertase subtilisin\/kexin type-9 (PCSK-9) in inflammation and diseases","volume":"370","author":"Brown","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.08.013","article-title":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II","volume":"266","author":"Gitt","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40618-019-01019-4","article-title":"Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: A systematic review and meta-analysis of randomized controlled trials","volume":"42","author":"Dicembrini","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"617249","DOI":"10.3389\/fcvm.2021.617249","article-title":"Association Between Circulating Proprotein Convertase Subtilisin\/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis","volume":"8","author":"Zhou","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Scalise, V., Sanguinetti, C., Neri, T., Cianchetti, S., Lai, M., Carnicelli, V., Celi, A., and Pedrinelli, R. (2021). PCSK9 Induces Tissue Factor Expression by Activation of TLR4\/NFkB Signaling. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312640"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4149\/gpb_2019057","article-title":"PCSK9 promotes the secretion of pro-inflammatory cytokines by macrophages to aggravate H\/R-induced cardiomyocyte injury via activating NF-\u03baB signalling","volume":"39","author":"Yang","year":"2020","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Cammisotto, V., Baratta, F., Castellani, V., Bartimoccia, S., Nocella, C., D\u2019Erasmo, L., Cocomello, N., Barale, C., Scicali, R., and Di Pino, A. (2021). Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137193"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S1734-1140(13)71068-5","article-title":"Can the antiplatelet effects of cangrelor be reliably studied in mice under in vivo and in vitro conditions using flow cytometry?","volume":"65","author":"Kassassir","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCRESAHA.115.307016","article-title":"Platelet-Mediated Thrombosis: From Bench to Bedside","volume":"118","author":"Gurbel","year":"2016","journal-title":"Circ. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","article-title":"PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver","volume":"35","author":"Demers","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2","volume":"283","author":"Poirier","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-012-0977-6","article-title":"PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling","volume":"69","author":"Kysenius","year":"2012","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"j1648","DOI":"10.1136\/bmj.j1648","article-title":"Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: Mendelian randomisation study","volume":"357","author":"Benn","year":"2017","journal-title":"BMJ"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/eurheartj\/ehs084","article-title":"Antisense oligonucleotides for the treatment of dyslipidaemia","volume":"33","author":"Visser","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/ATVBAHA.116.307227","article-title":"CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes in vivo-Brief Report","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.114.214221","article-title":"Pharmacologic profile of the Adnectin BMS-962476, a small protein biologic alternative to PCSK9 antibodies for low-density lipoprotein lowering","volume":"350","author":"Mitchell","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Momtazi-Borojeni, A.A., Jaafari, M.R., Banach, M., Gorabi, A.M., Sahraei, H., and Sahebkar, A. (2021). Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates. Vaccines, 9.","DOI":"10.3390\/vaccines9070749"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Safaeian, L., Mirian, M., and Bahrizadeh, S. (2020). Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H2O2-induced oxidative stress. Arch. Physiol. Biochem., 1\u20136.","DOI":"10.1080\/13813455.2020.1788605"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"eabe9117","DOI":"10.1126\/scitranslmed.abe9117","article-title":"An oral antisense oligonucleotide for PCSK9 inhibition","volume":"13","author":"Gennemark","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"105562","DOI":"10.1016\/j.phrs.2021.105562","article-title":"New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice","volume":"167","author":"Ma","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Reki\u0107, D., Azarov, I., Kn\u00f6chel, J., Sokolov, V., Nilsson, C., Wernevik, L., Han, D., Ryd\u00e9n-Bergsten, T., Ebrahimi, A., and Dota, C. (2022). AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval. Br. J. Clin. Pharmacol.","DOI":"10.1111\/bcp.15425"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.5114\/aoms\/133885","article-title":"PCSK9 immunization using nanoliposomes: Preventive efficacy against hypercholesterolemia and atherosclerosis","volume":"17","author":"Jaafari","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"17732","DOI":"10.1074\/jbc.M113.541094","article-title":"Annexin A2 reduces PCSK9 protein levels via a translational mechanism and interacts with the M1 and M2 domains of PCSK9","volume":"289","author":"Ly","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"102650","DOI":"10.1016\/j.ebiom.2020.102650","article-title":"A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1\/3 and HNF1alpha","volume":"52","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1074\/jbc.M113.514067","article-title":"Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor","volume":"289","author":"Zhang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cvr\/cvy128","article-title":"PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy","volume":"114","author":"Ding","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_65","unstructured":"(2022, August 05). Available online: https:\/\/www.merck.com."},{"key":"ref_66","unstructured":"(2022, August 05). A Study of the Efficacy and Safety of MK-0616 (Oral PCSK9 Inhibitor) in Adults with Hypercholesterolemia (MK-0616-008), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT05261126?intr=MK-0616&draw=2&rank=2."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa1701488","article-title":"Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients","volume":"376","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","article-title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): A randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S2213-8587(19)30158-5","article-title":"Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: A prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","volume":"7","author":"Ray","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/1871530320666200213114138","article-title":"PCSK9 Inhibitors: From Nature\u2019s Lessons to Clinical Utility","volume":"20","author":"Raal","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.drudis.2022.01.014","article-title":"Development of small-molecule PCSK9 inhibitors for the treatment of hypercholesterolemia","volume":"27","author":"Ahamad","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1093\/eurheartj\/ehab299","article-title":"PCSK9 vaccine: So near, yet so far!","volume":"42","author":"Sahebkar","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2019.02.001","article-title":"Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system","volume":"283","author":"Jaafari","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Momtazi-Borojeni, A.A., Jaafari, M.R., Badiee, A., Banach, M., and Sahebkar, A. (2019). Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis. BMC Med., 17.","DOI":"10.1186\/s12916-019-1457-8"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11883-017-0668-8","article-title":"Treatment of Dyslipidemia Using CRISPR\/Cas9 Genome Editing","volume":"19","author":"Chadwick","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.omtm.2021.02.005","article-title":"In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Ther.-Methods Clin. Dev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.115.304351","article-title":"Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing","volume":"115","author":"Ding","year":"2014","journal-title":"Circ. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_79","unstructured":"(2022, August 01). A Study of VERVE-101 in Patients with Familial Hypercholesterolemia and Cardiovascular Disease, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05398029?cond=Verve-101&draw=2&rank=1."},{"key":"ref_80","first-page":"417","article-title":"Guidelines for primary diagnosis and treatment of dyslipidemia (2019)","volume":"018","author":"Association","year":"2019","journal-title":"Chin. J. Gen. Pract."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCULATIONAHA.113.007012","article-title":"Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial","volume":"129","author":"Koren","year":"2014","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/187153008786848286","article-title":"Further LDL cholesterol lowering through targeting PCSK9 for coronary artery disease","volume":"8","author":"Cao","year":"2008","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","article-title":"A 52-week placebo-controlled trial of evolocumab in hyperlipidemia","volume":"370","author":"Blom","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/ijmm.2021.4886","article-title":"PCSK9 mediates the oxidative low-density lipoprotein-induced pyroptosis of vascular endothelial cells via the UQCRC1\/ROS pathway","volume":"47","author":"Zeng","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Toscano, A., Cinquegrani, M., Scuruchi, M., Di Pino, A., Piro, S., Ferrara, V., Morace, C., Lo Gullo, A., Imbalzano, E., and Purrello, F. (2022). PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy. Biomolecules, 12.","DOI":"10.3390\/biom12040562"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1111\/jcmm.14586","article-title":"PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia\/reperfusion injury: Benefits beyond lipid-lowering effects","volume":"23","author":"Palee","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10496","DOI":"10.1038\/s41598-018-28777-0","article-title":"Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor","volume":"8","author":"Grin","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000442976","article-title":"Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis","volume":"8","author":"Boyd","year":"2016","journal-title":"J. Innate Immun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MCC.0000000000000351","article-title":"Role of lipoproteins and proprotein convertase subtilisin\/kexin type 9 in endotoxin clearance in sepsis","volume":"22","author":"Walley","year":"2016","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/SHK.0000000000000682","article-title":"Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis","volume":"46","author":"Dwivedi","year":"2016","journal-title":"Shock"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2687692","DOI":"10.1155\/2020\/2687692","article-title":"PCSK9: A Potential Therapeutic Target for Sepsis","volume":"2020","author":"Yuan","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1038\/s41598-019-46745-0","article-title":"Reduced Proprotein convertase subtilisin\/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients","volume":"9","author":"Leung","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Shaler, C.R., Joshua, C., Rudak, P.T., Arash, M., Szabo, P.A., Tun-Abraham, M.E., Jamie, R., Corbett, A.J., James, M.C., and Mccormick, J.K. (2017). MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathol. PLoS Biol., 15.","DOI":"10.1371\/journal.pbio.2001930"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Laudanski, K. (2021). Humanized Mice as a Tool to Study Sepsis\u2014More Than Meets the Eye. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052403"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/CCM.0000000000004487","article-title":"Proprotein Convertase Subtilisin\/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host with Septic Shock","volume":"48","author":"Atreya","year":"2020","journal-title":"Crit. Care Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/joim.13150","article-title":"PCSK9 is associated with mortality in patients with septic shock: Data from the ALBIOS study","volume":"289","author":"Bonaventura","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10238-020-00658-9","article-title":"Plasma PCSK9 levels and sepsis severity: An early assessment in the emergency department","volume":"21","author":"Innocenti","year":"2021","journal-title":"Clin. Exp. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/joim.12946","article-title":"Reduced plasma PCSK9 response in patients with bacteraemia is associated with mortality","volume":"286","author":"Rannikko","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jhep.2006.09.024","article-title":"The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus","volume":"46","author":"Molina","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2013.00119","article-title":"The role of cholesterol metabolism and cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer therapeutics","volume":"4","author":"Cruz","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"188581","DOI":"10.1016\/j.bbcan.2021.188581","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): A potential multifaceted player in cancer","volume":"1876","author":"Bhattacharya","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s13238-021-00821-2","article-title":"Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling","volume":"12","author":"Yuan","year":"2021","journal-title":"Protein Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jacl.2018.03.088","article-title":"Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab","volume":"12","author":"Ridker","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk","volume":"139","author":"Fazio","year":"2019","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.120.046397","article-title":"The Effect of PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism","volume":"141","author":"Marston","year":"2020","journal-title":"Circulation"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An Exploratory Analysis of Proprotein Convertase Subtilisin\/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial","volume":"5","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/s41467-018-06467-9","article-title":"A Mendelian randomization study of the effects of blood lipids on breast cancer risk","volume":"9","author":"Nowak","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"100130","DOI":"10.1016\/j.jlr.2021.100130","article-title":"The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer","volume":"62","author":"Seidah","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): A randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2017.12.008","article-title":"Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia","volume":"12","author":"Hartgers","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes","volume":"375","author":"Ference","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/19\/2972\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:38:19Z","timestamp":1760143099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/19\/2972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":116,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["cells11192972"],"URL":"https:\/\/doi.org\/10.3390\/cells11192972","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}